Sponsor or institution
Clinical trials and research at Nuvalent Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Nuvalent Inc. that are recruiting, at sites in 29 countries (most in Australia (4), Canada (4), United States (4)). By phase: Phase 1/2 (2), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 29Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Treatment for advanced ALK-positive non-small cell lung cancer | Phase 3 | Glendale, Arizona and 158 other locations | Recruiting | Jan 9, 2025 |
| Evaluating NVL-330 for advanced HER2-altered lung cancer | Phase 1 | Irvine, California and 20 other locations | Recruiting | Jul 26, 2024 |
| Evaluating NVL-655 for Advanced ALK-Positive Solid Tumors | Phase 1/2 | Orange, California and 73 other locations | Recruiting | May 20, 2022 |
| Evaluating NVL-520 for Advanced ROS1-positive Solid Tumors | Phase 1/2 | Orange, California and 62 other locations | Recruiting | Nov 12, 2021 |
All recruiting trials (4)
-
Treatment for advanced ALK-positive non-small cell lung cancer
This study is testing whether a new drug called neladalkib can help people with advanced ALK-positive non-small cell lung cancer live longer without their disease getting worse compared to the standard treatment, alectinib.
-
Evaluating NVL-330 for advanced HER2-altered lung cancer
This study is testing a new treatment called NVL-330 to see if it can safely help people with advanced lung cancer that has changes in the HER2 gene.
-
Evaluating NVL-655 for Advanced ALK-Positive Solid Tumors
This study is testing a new drug called NVL-655 to see if it can safely help people with advanced ALK-positive solid tumors, including non-small cell lung cancer.
-
Evaluating NVL-520 for Advanced ROS1-positive Solid Tumors
This study is testing a new drug called NVL-520 to see if it can safely help people with advanced solid tumors that have a specific genetic change called ROS1.
Quick answers
How many clinical trials run by Nuvalent Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 29 countries. The most sites are in Australia (4 trials), Canada (4 trials), United States (4 trials), Belgium (3 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.